Specialty Capsules Market Size, Share and Global Trend By Product Type (Hard Capsules, Softgel Capsules), By Application (Dietary supplements, Cosmetics, Lifestyle Products), By End User (Pharmaceutical companies, Nutraceutical companies, Cosmetics companies, Research institutions and organization,Others) and Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
Oral solid dosage drugs can be formulated in a tablet or capsule form. Specialty capsules refer to the capsules that are manufactured using a different kind of raw materials embedded with required medical formulations. Specialty capsules are used for the treatment of various disorders or used as a dietary supplement. Specialty capsules mainly consist of hard capsules and softgel gelatin capsules. Specialty capsules are also crucial for the concept of customized medicines, which utilizes customized medical formulations stored in specialty capsules for the patient.
Specialty capsules also lead to the prospect of personalized medicine for the treatment of cancers and other infectious, acute, and chronic diseases. According to the world health organization (WHO), chronic diseases such as heart disease, cancers are the foremost causes of death worldwide. Ischemic heart disease was responsible for about 9.43 million deaths, and cardiovascular diseases were responsible for 17.8 million deaths worldwide in 2018, thus increasing the demand for medications and propelling the specialty capsules market.
To gain extensive insights into the market, Request for Customization
The global specialty capsules market is anticipated to grow owing to the safety of drugs formulated in the capsules, and low risk of cross-linkage reactions. Also, rise in communicable diseases worldwide thus demanding for effective therapeutics, increase in the research & development activities, awareness & adoption of specialty capsules, and widespread usage of tailored treatments or therapies are responsible for driving the global specialty capsules market during the forecast period.
The factor limiting the growth of the global specialty capsules market is the high cost associated with the formulations than that of a tablet. Also, the high raw material cost involved in manufacturing of specialty capsule is likely to hamper the specialty capsules market during the forecast period.
Key Players Covered
Some of the major companies that are present in the global specialty capsules market are Capsugel, ACG, Capsuline, GELNEX, GELITA AG, Rousselot, Tessenderlo Group, NITTA GELATIN NA INC., and others.
SEGMENTATION
SEGMENTATION | DETAILS |
By Product Type | · Hard Capsules · Softgel Capsules |
By Application | · Dietary supplements · Cosmetics · Lifestyle Products |
By End User | · Pharmaceutical companies · Nutraceutical companies · Cosmetics companies · Research institutions and organization · Others |
By Geography | · North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
Pharmaceutical companies in the end-user segment hold the highest share in terms of revenue owing to the demand of drugs in the form of capsules for the treatment and prevention of various diseases.
Key Insights
- Overview of technological development in the specialty capsules market
- New product launch
- Pricing analysis
- Key mergers and acquisitions
Regional Analysis
Geographically the specialty capsules market is segmented by North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for the largest share in the global market due to the increasing prevalence of acute & chronic diseases, established healthcare system, high medical expenditure, access to advanced treatment options, demand for preventive care by diagnostic examinations, and high research funding for specialty capsules. The Asia Pacific is the fastest emerging market due to increasing incidences of infectious and serious diseases, a large patient pool, and demand for safe & better treatment solutions.
Key Industry Developments
- In May 2019, Lonza launched CAPSUGEL ZEPHYR, new dry-powder inhalation capsule for the treatment of pulmonary drug delivery.
- In August 2018, Sun Pharmaceutical Industries Ltd., launched Kapspargo Sprinkle (metoprolol succinate) extended-release capsules for the treatment of hypertension, angina pectoris and heart failure.
- Ongoing
- 2023
- 2019-2022
Personalize this Research
- Granular Research on Specified Regions or Segments
- Companies Profiled based on User Requirement
- Broader Insights Pertaining to a Specific Segment or Region
- Breaking Down Competitive Landscape as per Your Requirement
- Other Specific Requirement on Customization
Healthcare Clients
